BIW-8556

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBIW-8556
Drug Alias NameFlt1-targeting mAb (BioWa)VEGF-R-targeting mAb (BioWa)BIW-8556
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVascular endothelial growth factor receptor 1 antagonists
TargetsVascular endothelial growth factor receptor 1
Therapy Area/IndicationsColonic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiowa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiowa Inc
Active IndicationsN/A
Inactive IndicationsColonic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A